FOR IMMEDIATE RELEASE

Manhattan Scientifics Delivers Fuel Cell Unit To U.S. Army

New York, NY - February 9, 2004 - Manhattan Scientifics, Inc. (MHTX) announced today that it has delivered a 700-watt NovArs prototype fuel cell system to the U.S. Army under a contract received in the third quarter of last year. The contract was awarded as part of the Army's Communications-Electronics Command's (CECOM) competitive Foreign Technology Evaluation Program.

Manhattan Scientifics' management said the unit is being evaluated by CECOM with other units as a possible battery charger for tactical units.

A prototype NovArs fuel cell unit of the type being evaluated by the Department of Defense Fuel Cell Test and Evaluation Center (FCTec) was featured in several fuel cell publications and showcased at a recent fuel cell conference in Florida. A copy of the article can be accessed by visiting the MHTX website at http://www.mhtx.com/.

Manhattan Scientifics' COO Jack Harrod said, "We are pleased that the Department of Defense is testing our NovArs fuel cell technology. It is too early to speculate on the long term implications of this activity."


About Manhattan Scientifics
Manhattan Scientifics, Inc. (www.mhtx.com) is a technology development company working in the fields of alternative energy, and computer touch technology. The company's development laboratories are located in Los Alamos and Albuquerque, New Mexico. Its executive facility is located in New York City. Copies of Manhattan Scientifics' press releases, current quotes, stock charts and other information for investors may be found on the website www.hawkassociates.com
www.hawkmicrcocaps.com

The foregoing press release contains forward-looking statements (including expectation of future events), which are subject to risks, and uncertainty, which may be beyond the company's control. Actual results could differ materially for many reasons including but not limited to completion of R&D and successful commercialization of products/services, patent completion, prosecution and defense against well-capitalized competitors. These are serious risks and there is no assurance that our forward-looking statements will occur or prove to be accurate.

Executive Contacts:

Marvin Maslow, CEO, Manhattan Scientifics (917) 923-3300.
Email:maslow@ix.netcom.com

Jack Harrod
Chief Operating Officer
Manhattan Scientifics, Inc.
214.675.8033
Email:harrod@airmail.net

Media Contact: Richard Rubenstein, Rubenstein PR (212) 843-9222
Email: rruben@rpr1.com

Investor Relations Contact:
Frank Hawkins, (Hawk Associates) (305) 852-2383
Email: Info@hawkassociates.com

######END######

**********

Manhattan Scientifics, Inc. Olympic Tower, 641 Fifth Avenue, Suite 36F, New York, NY 10022 Tel: (212) 752-0505 Fax: (212) 752-0077 - http://www.mhtx.com


Media Contact:
Richard Rubenstein,
Rubenstein PR
Tel: (212) 843-9222
Email:
RRubenstein@rubensteinpr.com
Website: http://www.rubensteinpr.com/index.htm

Institutional Investor Relations:
Frank Hawkins/Julie Marshall
Hawk Associates
Tel: (305) 852-2383
Email: Fhawk@hawkassociates.com
http://www.hawkassociates.com